Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06334393
Status:
RECRUITING
Last Update Posted:
2024-03-28
First Post:
2024-03-06
Brief Title:
Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated Adjuvanted Whole Zika Virus Vaccine Candidate VLA1601 in Healthy Adults
Sponsor:
Valneva Austria GmbH
Organization:
Valneva Austria GmbH